Synthetic vaccine nanoparticles target to lymph node triggering enhanced innate and adaptive antitumor immunity.
Sign Up to like & getrecommendations! Published in 2017 at "Biomaterials"
DOI: 10.1016/j.biomaterials.2017.03.034
Abstract: In this study, synthetic vaccine nanoparticles (SVNPs) that efficiently targeted lymph nodes, where immune responses against foreign antigens are primed, were developed to enhance antitumor immunity. The size (20-70 nm) and surface character (amination) of poly(γ-glutamic… read more here.
Keywords: vaccine nanoparticles; immunity; antitumor immunity; synthetic vaccine ... See more keywords